Subscribe to Pritikin Longevity Center’s news feed.
Click on “Follow” and decide if you want to get news from Pritikin Longevity Center via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to Pritikin Longevity Center comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from Pritikin Longevity Center which you are really interested in. Click on the blue “Filter” button below to get started.
Website title: Pritikin Longevity Center
Is this your feed? Claim it!
Most of us learned to think about exercise in blocks of time: walk for 30 minutes, ride the stationary bike for 20, get 150 minutes of moderate cardio each week. Those numbers are easy to remember and easy to track, and for aerobic exercise they work reasonably well.
Strength tra...
The FDA approved Zepbound® (tirzepatide) for chronic weight management on November 8, 2023. Developed by Eli Lilly, it was the first medication of its kind — and it prod...
Obesity has become an epidemic in the United States and around the world. As a result, many people are turning to weight loss medications like semaglutide to help them lose weight and k...
In the quest to achieve weight loss goals, individuals are often presented with a multitude of options, ranging from natural approaches like diet and exercise to medical interventions such as weight loss injections. Zepbound (tirzepatide), a relatively new entry into the market, has garnered attention for its potential benefits and distinctions ...
Ozempic® and Wegovy® contain the same active ingredient — semaglutide — and are made by the same manufacturer, Novo Nordisk. Yet they are approved for different purposes, dosed differently, and priced differently. If you are trying to unders...